Disseminated BCG Infection and Primary Immunodeficiencies: A Report from Two Tertiary Centers
暂无分享,去创建一个
Shima Baradaran | Z. Chavoshzadeh | A. Karimi | S. Darougar | S. Fahimzad | S. Armin | D. Babaie | S. Mahdaviani | R. Ghanaie | S. Tabatabaei | M. Mesdaghi | M. Mansouri
[1] A. Alrabiaah,et al. Disseminated bacille Calmette-Guérin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome. , 2016, European review for medical and pharmacological sciences.
[2] A. Velayati. Tuberculosis in children , 2016, International journal of mycobacteriology.
[3] Amitabh Singh,et al. Disseminated BCG Disease in an Infant with Severe Combined Immunodeficiency , 2016 .
[4] B. Geramizadeh,et al. Post-Vaccination Disseminated Bacillus Calmette Guerin Infection Among Children in Southern Iran , 2015, Jundishapur journal of microbiology.
[5] M. Alshehri,et al. Bacillus Calmette–Guérin vaccine related lymphadenitis in children: Management guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS) , 2015, International journal of pediatrics & adolescent medicine.
[6] Z. Memish,et al. Molecular Confirmation of Bacillus Calmette Guerin Vaccine Related Adverse Events among Saudi Arabian Children , 2014, PloS one.
[7] Jinqiao Sun,et al. Clinical Characteristics and Immunogenetics of BCGosis/BCGitis in Chinese Children: A 6 Year Follow-Up Study , 2014, PloS one.
[8] O. Parkash. How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis? , 2014, International journal of mycobacteriology.
[9] J. Black,et al. Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges. , 2014, International journal of mycobacteriology.
[10] M. S. Rezai,et al. BCG-osis after BCG vaccination in immunocompromised children: Case series and review , 2014 .
[11] E. Goudouris,et al. Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. , 2014, Journal of investigational allergology & clinical immunology.
[12] A. McLellan,et al. Extracellular forms of Mycobacterium bovis BCG in the mucosal lymphatic tissues following oral vaccination. , 2013, International journal of mycobacteriology.
[13] S. Rosenzweig,et al. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. , 2012, The Journal of infection.
[14] S. Papanicolaou,et al. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands. , 2012, The Journal of infection.
[15] N. Rezaei,et al. Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[16] M. S. Rezai,et al. Disseminated Bacillus Calmette-Guerin infection after BCG vaccination. , 2008, Journal of tropical pediatrics.
[17] P. Rosenthal,et al. Pattern of malaria-specific T-cell responses in a cohort of Ugandan children. , 2007, Journal of tropical pediatrics.
[18] J. Casanova,et al. Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency , 2007, Emerging infectious diseases.
[19] Noorbakhsh Samileh,et al. Type of Immunodeficiency, Treatment and Outcomes of Serious BCG Vaccine Complications: A 15 Year Survey , 2007 .
[20] S. Mamishi,et al. Disseminated Mycobacterium bovis infection after BCG vaccination. , 2006, Iranian journal of allergy, asthma, and immunology.
[21] Grange Jm,et al. Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. , 1998, Communicable disease and public health.
[22] A. Fischer,et al. Immunological conditions of children with BCG disseminated infection , 1995, The Lancet.